Literature DB >> 16554997

Effectiveness of steroid treatment for hoarseness caused by idiopathic fibrosing mediastinitis: report of a case.

Hideo Ichimura1, Shigemi Ishikawa, Tatsuo Yamamoto, Masataka Onizuka, Yukinori Inadome, Masayuki Noguchi, Yuzuru Sakakibara.   

Abstract

A 65-year-old woman was referred to our department for investigation and treatment of hoarseness. A chest computed tomography (CT) scan showed a mediastinal mass spreading into the aortopulmonary window. This finding and that of flexible laryngoscopy suggested that the hoarseness was being caused by left recurrent nerve involvement resulting in left vocal cord paralysis. Thus, we performed a mediastinoscopic biopsy via a parasternal incision. Pathological examination revealed dense fibrous tissue infiltrated with varied inflammatory cells. Because no etiological pathogen or neoplastic lesion was identified, we diagnosed idiopathic fibrosing mediastinitis and began treating the patient with prednisolone. After a course of treatment, the mediastinal lesion showed a remarkable response. The hoarseness resolved as the lesion became smaller. Laryngoscopy confirmed recuperation of vocal cord function. This report shows that steroid therapy is a treatment option for hoarseness caused by recurrent laryngeal nerve involvement of fibrosing mediastinitis, if administered under close observation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554997     DOI: 10.1007/s00595-005-3161-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

Review 1.  Fibrosing mediastinitis.

Authors:  S E Rossi; H P McAdams; M L Rosado-de-Christenson; T J Franks; J R Galvin
Journal:  Radiographics       Date:  2001 May-Jun       Impact factor: 5.333

2.  Fibrosing mediastinitis with coronary artery involvement.

Authors:  A Cochrane; R Warren; M Mullerworth; E Manolas
Journal:  Ann Thorac Surg       Date:  1991-04       Impact factor: 4.330

Review 3.  Mediastinal fibrosis complicating histoplasmosis.

Authors:  J E Loyd; B F Tillman; J B Atkinson; R M Des Prez
Journal:  Medicine (Baltimore)       Date:  1988-09       Impact factor: 1.889

4.  Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases.

Authors:  C G Schowengerdt; R Suyemoto; F B Main
Journal:  J Thorac Cardiovasc Surg       Date:  1969-03       Impact factor: 5.209

5.  The radiographic findings of fibrosing mediastinitis.

Authors:  A D Sherrick; L R Brown; G F Harms; J L Myers
Journal:  Chest       Date:  1994-08       Impact factor: 9.410

Review 6.  Mediastinal compression syndromes due to idiopathic fibrosing mediastinitis--report of three cases and review of the literature.

Authors:  G Kalweit; H Huwer; U Straub; E Gams
Journal:  Thorac Cardiovasc Surg       Date:  1996-04       Impact factor: 1.827

7.  Desmoplastic malignant mesothelioma masquerading as sclerosing mediastinitis: a diagnostic dilemma.

Authors:  T B Crotty; T V Colby; P C Gay; R J Pisani
Journal:  Hum Pathol       Date:  1992-01       Impact factor: 3.466

  7 in total
  4 in total

Review 1.  Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.

Authors:  Giovanni M Rossi; Giacomo Emmi; Domenico Corradi; Maria L Urban; Federica Maritati; Federica Landini; Paola Galli; Alessandra Palmisano; Augusto Vaglio
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

2.  Fibrosing Mediastinitis Presenting With Superior Vena Cava Syndrome.

Authors:  Jee Ha Park; Jon Lucaj; Krassimir L Denchev
Journal:  Cureus       Date:  2022-03-31

Review 3.  [Treatment of chronic mediastinitis].

Authors:  R Scheubel
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

Review 4.  Clinical Features of Fibrosing Mediastinitis in Japanese Patients: Two Case Reports and a Literature Review.

Authors:  Yoichi Kobayashi; Takashi Ishiguro; Yotaro Takaku; Naho Kagiyama; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Intern Med       Date:  2021-05-22       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.